Teotia evaluates skin thickness, elasticity, and muscle tone to determine whether a hidden central neck excision alone is appropriate
11 GLP-1R Arg 299 and Trp 306 may interact with GLP-1 His 7
Update on treatments for nonmotor symptoms of Parkinsons diseasean evidencebased medicine review
GLP-1s not found to increase risk of ischemic optic neuropathy Several observational studies have suggested that GLP-1 treatment in people with diabetes may increase the risk of non-arteritic anterior ischemic optic neuropathy (NAION), a condition that can cause blindness
GLP-1 receptor agonists are medications originally developed for type 2 diabetes and later approved for chronic weight management
Several possible explanations for changes in urinary frequency include: Improved glycaemic control : As Ozempic helps lower blood glucose levels, patients with previously poorly controlled diabetes may notice reduced urination compared to their baseline, as high blood sugar itself causes increased urination (polyuria) Dietary changes : Some patients alter their fluid intake or dietary habits when starting Ozempic, particularly as the medication often reduces appetite Weight loss : Weight reduction, which commonly occurs with Ozempic treatment for type 2 diabetes, may influence fluid balance Other common causes of increased urination unrelated to Ozempic include: Urinary tract infections Enlarged prostate in men Caffeine or alcohol consumption Other medications, particularly diuretics Anxiety It's important to note that Ozempic is licensed in the UK for the treatment of type 2 diabetes, while Wegovy (also semaglutide) is the licensed product for weight management
